Sealed Air’s Diversey Care division has announced it has acquired the UVC disinfection portfolio of Daylight Medical, a manufacturer of innovative medical devices. The portfolio acquired includes UVC disinfectant technologies designed to disinfect rooms, surfaces, non-critical equipment, and devices. Daylight’s solutions are noted for their innovative, portable and affordable design, allowing safe and targeted dosing of UVC light to quickly and effectively kill harmful pathogens, including bacteria and C. difficile. The agreement also gives Diversey Care access to a robust innovation pipeline.
“When combined with consistent and proper manual cleaning and disinfection, UVC disinfection technology has the power to reduce the spread of pathogens that can cause dangerous infections,” said Dr. Ilham Kadri, president, Diversey Care. “Daylight’s innovations are a synergistic fit with our existing infection prevention platform, which includes key innovations such as Accelerated Hydrogen Peroxide (AHP)-based disinfectants. Adjunct technologies, such as these no-touch disinfection devices, will allow all facilities concerned with preventing infection, from hospitals to schools to airports, to add an additional level of assurance to their existing protocols.”
Included in the acquisition are the MoonBeam3 UVC disinfection system, and the Sky 6Xi and 7Xi devices. The MoonBeam3 is a lightweight, portable device designed for area, room and non-critical equipment disinfection. The device has three articulating arms designed to optimise the UVC dose delivered to surfaces.
The Sky 6Xi and 7Xi are designed for tablet and phone disinfection, an important source of risk which needs to be addressed as usage of these devices increases for staff, visitors and patients. These compact devices can be placed around the facility, making it easy and convenient to effectively remove pathogens from mobile devices.
“Daylight’s easy-to-use technologies allow for highly effective disinfection at the lowest overall cost, enabling facilities to incorporate these devices into daily cleaning and disinfection protocols with minimal training,” said Peter Botten, owner, Daylight Medical. “We’re thrilled that this technology will be incorporated into Diversey’s portfolio of infection prevention solutions because we recognise that partnering with an infection prevention leader can provide the mechanism to bring this valuable technology to facilities across the world.”Visit: http://www.daylightmedical.com